Case Number:

IPR2023-00551

Case Type:

IPR

Status:

Terminated-Settled

Petitioner:

Fusion Pharmaceuticals, Inc.

1. Filed: February 13, 2023 00:00

   Coverage

   1. August 17, 2023

      PTAB To Eye Cancer Treatment IP Over EU Branch Objections

      The Patent Trial and Appeal Board has agreed to review a cancer treatment patent owned by a German university and an atomic energy organization associated with the European Commission.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login